Adverse events808

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 808

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	Substudy 1: Ruxolitinib + Regorafenib	10	85
other	Anaemia	Blood and lymphatic system disorders	Substudy 1: Placebo + Regorafenib	12	86
other	Anaemia	Blood and lymphatic system disorders	Substudy 2: Ruxolitinib + Regorafenib	27	106
other	Anaemia	Blood and lymphatic system disorders	Substudy 2: Placebo + Regorafenib	12	106
other	Hypothyroidism	Endocrine disorders	Substudy 1: Ruxolitinib + Regorafenib	2	85
other	Hypothyroidism	Endocrine disorders	Substudy 1: Placebo + Regorafenib	6	86
other	Hypothyroidism	Endocrine disorders	Substudy 2: Ruxolitinib + Regorafenib	4	106
other	Hypothyroidism	Endocrine disorders	Substudy 2: Placebo + Regorafenib	3	106
other	Abdominal pain	Gastrointestinal disorders	Substudy 1: Ruxolitinib + Regorafenib	21	85
other	Abdominal pain	Gastrointestinal disorders	Substudy 1: Placebo + Regorafenib	24	86
other	Abdominal pain	Gastrointestinal disorders	Substudy 2: Ruxolitinib + Regorafenib	24	106
other	Abdominal pain	Gastrointestinal disorders	Substudy 2: Placebo + Regorafenib	26	106
other	Abdominal pain upper	Gastrointestinal disorders	Substudy 1: Ruxolitinib + Regorafenib	4	85
other	Abdominal pain upper	Gastrointestinal disorders	Substudy 1: Placebo + Regorafenib	6	86
other	Abdominal pain upper	Gastrointestinal disorders	Substudy 2: Ruxolitinib + Regorafenib	6	106
other	Abdominal pain upper	Gastrointestinal disorders	Substudy 2: Placebo + Regorafenib	11	106
other	Ascites	Gastrointestinal disorders	Substudy 1: Ruxolitinib + Regorafenib	6	85
other	Ascites	Gastrointestinal disorders	Substudy 1: Placebo + Regorafenib	2	86
other	Ascites	Gastrointestinal disorders	Substudy 2: Ruxolitinib + Regorafenib	2	106
other	Ascites	Gastrointestinal disorders	Substudy 2: Placebo + Regorafenib	7	106

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02119676/events

API reference For AI assistants

Adverse events808

Sources 3

Read this list from software.